Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongwei Xia

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
ISA Transactions|June 5, 2019
Adaptive control of a switched hypersonic vehicle model robust to scramjet choking and elevator faultHao An, Hongwei Xia, Guangcheng Ma, et al.
Biochemical and Biophysical Research Communications|February 22, 2022
Identification and characterization of inhibitory nanobody against p38δChenliang Zhang, Qiulin Tang, Hongwei Xia, et al.
Molecular Cancer|November 7, 2021
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancerGongmin Zhu, Lijiao Pei, Hongwei Xia, et al.
International Journal of Oncology|October 5, 2022
[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cellsQiulin Tang, Mingxing Li, Liang Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2021
PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteinsChenliang Zhang, Qiulin Tang, Hongwei Xia, et al.
Translational Cancer Research|July 11, 2024
Benefits of adjuvant chemotherapy in elderly patients with stage IB-IIIB non-small cell lung cancer: a propensity-matched analysisXuan Qin, Xiangzhi Xiao, Hongwei Xia, et al.
Molecular Cancer Therapeutics|September 27, 2019
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK PathwaySheng Zhou, Huanji Xu, Qiulin Tang, et al.
Cancer Letters|November 16, 2018
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancersXinyu Dai, Hongwei Xia, Sheng Zhou, et al.
International Journal of Oncology|August 2, 2018
miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cellsQiulin Tang, Mingxing Li, Liang Chen, et al.
The Journal of Physical Chemistry Letters|March 23, 2026
Atomically Thin InSbSe<sub>3</sub> Layers for Multispectral Optical Imaging with Fast Photoresponse and Broadband PhotodetectionYongjie Fan, RuiYa Xu, Wen Yang, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
ISA Transactions|June 5, 2019
Adaptive control of a switched hypersonic vehicle model robust to scramjet choking and elevator faultHao An, Hongwei Xia, Guangcheng Ma, et al.
Biochemical and Biophysical Research Communications|February 22, 2022
Identification and characterization of inhibitory nanobody against p38δChenliang Zhang, Qiulin Tang, Hongwei Xia, et al.
Molecular Cancer|November 7, 2021
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancerGongmin Zhu, Lijiao Pei, Hongwei Xia, et al.
International Journal of Oncology|October 5, 2022
[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cellsQiulin Tang, Mingxing Li, Liang Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2021
PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteinsChenliang Zhang, Qiulin Tang, Hongwei Xia, et al.
Translational Cancer Research|July 11, 2024
Benefits of adjuvant chemotherapy in elderly patients with stage IB-IIIB non-small cell lung cancer: a propensity-matched analysisXuan Qin, Xiangzhi Xiao, Hongwei Xia, et al.
Molecular Cancer Therapeutics|September 27, 2019
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK PathwaySheng Zhou, Huanji Xu, Qiulin Tang, et al.
Cancer Letters|November 16, 2018
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancersXinyu Dai, Hongwei Xia, Sheng Zhou, et al.
International Journal of Oncology|August 2, 2018
miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cellsQiulin Tang, Mingxing Li, Liang Chen, et al.
The Journal of Physical Chemistry Letters|March 23, 2026
Atomically Thin InSbSe<sub>3</sub> Layers for Multispectral Optical Imaging with Fast Photoresponse and Broadband PhotodetectionYongjie Fan, RuiYa Xu, Wen Yang, et al.
Pageof 9